Troglitazone inhibits PPARγ expression in mononuclear cells in obese non-diabetic subjects

被引：0
|
作者：
Aljada, A
Ghanim, H
Assian, E
Garg, R
Mohanty, P
Dandona, P
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
424
引用
收藏
页码：A105 / A105
页数：1
相关论文
共 50 条
  • [21] Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients
    Paquot, N
    Scheen, AJ
    Dirlewanger, M
    Lefèbvre, PJ
    Tappy, L
    OBESITY RESEARCH, 2002, 10 (03): : 129 - 134
  • [22] GLUCOSE METABOLITES IN BLOOD AND ADIPOSE-TISSUE OF OBESE DIABETIC AND NON-DIABETIC SUBJECTS
    PAGE, MA
    GALTON, DJ
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1975, 49 (01): : 27 - 32
  • [23] FFA stimulate insulin secretion equally in obese diabetic and non-diabetic subjects.
    Boden, G
    Chen, XH
    DIABETES, 1997, 46 : 800 - 800
  • [24] Expression of the beta(3)-adrenoceptor gene polymorphism (Trp64Arg) in obese diabetic and non-diabetic subjects
    Jeyasingam, CL
    Bryson, JM
    Caterson, ID
    Yue, DK
    Donnelly, R
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) : 733 - 735
  • [25] An inducer of glyoxalase 1 down regulates inflammatory gene expression in overweight and obese non-diabetic subjects
    Xue, M.
    Weickert, M. O.
    Qureshi, S.
    Kandala, N. -B.
    Anwar, A.
    Waldron, M.
    Shafie, A.
    Rabbani, N.
    Thomalley, P. J.
    DIABETOLOGIA, 2016, 59 : S300 - S300
  • [26] Troglitazone inhibits expression of the PEPCK gene by a PPARγ-independent mechanism
    Roesler, WJ
    Khandelwal, RL
    Davies, GF
    DIABETES, 2000, 49 : A212 - A212
  • [27] RELATIVE UNRESPONSIVENESS OF OBESE DIABETIC COMPARED TO OBESE NON-DIABETIC SUBJECTS TO WEIGHT-REDUCING EFFECT OF FENFLURAMINE
    OTIM, MA
    EAST AFRICAN MEDICAL JOURNAL, 1977, 54 (02) : 91 - 95
  • [28] Effect of troglitazone on glucose transport and glycogen synthase activity in human skeletal muscle cultures from obese non-diabetic and NIDDM subjects.
    Park, K
    Abrams, L
    Nikoulina, S
    Mudaliar, S
    Ciaraldi, T
    Henry, R
    DIABETES, 1996, 45 : 342 - 342
  • [29] ASSOCIATIONS OF CHEMERIN LEVELS AND LIPID SUBFRACTIONS IN NON-DIABETIC OBESE AND LEAN SUBJECTS
    Seres, I.
    Lorincz, H.
    Katko, M.
    Harangi, M.
    Somodi, S.
    Gaal, K.
    Fulop, P.
    Paragh, G.
    ATHEROSCLEROSIS, 2014, 235 (02) : E220 - E220
  • [30] Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects
    Gatti, Alessandra
    Morini, Eleonora
    De Cosmo, Salvatore
    Maiani, Francesca
    Mandosi, Elisabetta
    Fallarino, Mara
    Morano, Susanna
    Trischitta, Vincenzo
    OBESITY, 2008, 16 (04) : 899 - 901
12345